Sensorium Therapeutics

Boston, MA · Founded 2021 · Privately Held (backing)

Developer of a therapeutic discovery platform designed to identify compounds for treating brain and mental health conditions. Sensorium Therapeutics is based in Boston, MA and was founded in 2021. Its last reported valuation was $47 million in Sep 2022. It has raised $69.7 million across 3 recorded rounds; the latest was a $26.8 million early-stage round in Jan 2025.

Last reported valuation
$47.0M
Oct 2026
Priced at
—
Total raised
$69.7M
Last round
Early Stage VC
Jan 2025
What is Sensorium Therapeutics worth?
$47.0Mlast reported valuation · Oct 2026

Sensorium Therapeutics's last reported valuation, Sep 2022. Nothing priced has surfaced since.

Free account
More of Sensorium Therapeutics with a free account
  • ·The complete investor list: 16 names
  • ·Watch Sensorium Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Sensorium Therapeutics funding history

3 rounds
DateRoundRaisedPost-money
Jan 2025Early Stage VC$26.8M▮
Sep 2022Early Stage VC$24.7M▮
Jul 2021Early Stage VC$9.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Sensorium Therapeutics valuation

Sensorium Therapeutics's last reported valuation was $47 million in Sep 2022. No priced round, secondary trade or fund mark has surfaced since.

How much has Sensorium Therapeutics raised?

Sensorium Therapeutics has raised $69.7 million across 3 recorded rounds since 2021. The largest was a $9 million early-stage round in Jul 2021; the most recent was a $26.8 million early-stage round in Jan 2025.

Sensorium Therapeutics has filed 5 Form Ds with the SEC since 2021, most recently in Jul 2025 ($26.8 million sold to 19 investors).

How Sensorium Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Sensorium Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Sensorium Therapeutics

What is Sensorium Therapeutics worth?
Sensorium Therapeutics is valued at $47.0M as of Oct 2026. Sensorium Therapeutics's last reported valuation, Sep 2022. Nothing priced has surfaced since.
How much has Sensorium Therapeutics raised?
Sensorium Therapeutics has raised $69.7M in total funding across 3 recorded rounds.
When did Sensorium Therapeutics last raise?
Sensorium Therapeutics last raised in Jan 2025 (Early Stage VC), raising $26.8M.